Pacific Biosciences And GenDx Initiate Co-Marketing Activities For Full-Length HLA Gene Sequencing Products

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

UTRECHT, The Netherlands and MENLO PARK, Calif., June 19, 2014 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II DNA Sequencing System, and GenDx, a pioneer in the area of sequence-based typing and next-generation sequencing for HLA typing, today announced a co-marketing agreement to offer products for full-length HLA gene sequencing.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC